Tarlov Disease (Perineural Cyst) – A Complete Patient Guide

Overview

Tarlov disease, also known as a perineural (Tarlov) cyst, is a fluid‑filled sac that forms around the nerve root sheath, most commonly in the sacral (lower back) region of the spine. The cyst is lined by the same tissue that surrounds nerve fibers and is filled with cerebrospinal fluid (CSF). While many Tarlov cysts are discovered incidentally on imaging and never cause problems, some become symptomatic and are collectively referred to as “Tarlov disease.”

Who it affects: The condition primarily affects adults between the ages of 30 and 60, with a slight female predominance (approximately 55‑60% of reported symptomatic cases). It is rare in children, but can appear after spinal trauma at any age.

Prevalence: Autopsy and MRI studies suggest that perineural cysts are present in 1–4% of the general population, yet only 0.5–1% become clinically significant enough to be diagnosed as Tarlov disease.¹ This discrepancy underscores that most cysts are benign and asymptomatic.

Symptoms

Symptoms arise when the cyst enlarges enough to compress adjacent nerve tissue, alter CSF dynamics, or cause inflammation. The presentation can be highly variable, ranging from mild discomfort to disabling pain.

Typical symptom cluster

• Low‑back or sacral pain – dull, aching, or sharp pain that worsens with prolonged sitting or standing.
• Pain radiating to the buttocks, thighs, or calves – often described as “sciatica‑like” but may not follow a classic dermatomal pattern.
• Perineal or genital discomfort – burning, tingling, or aching in the vulva, penis, scrotum, or perineum.
• Urinary symptoms – urgency, frequency, nocturia, or incomplete emptying; in rare cases, retention.
• Bowel dysfunction – constipation or fecal urgency.
• Sensory changes – numbness or paresthesia (pins‑and‑needles) in the saddle area (the region that would touch a saddle when riding).
• Motor weakness – occasional foot drop or difficulty walking if the cyst compresses motor fibers.
• Sexual dysfunction – decreased sensation, erectile problems, or painful intercourse.
• Post‑exertional fatigue – symptoms may flare after prolonged activity, especially walking or cycling.
• Positional relief or aggravation – pain may improve when lying flat and worsen when upright.

Less common manifestations

• Headaches (due to CSF pressure changes)
• Vertigo or balance problems
• Lower‑extremity edema (rare, linked to venous congestion)

Because many of these symptoms overlap with other spinal disorders (herniated disc, spinal stenosis, pelvic floor dysfunction), a thorough evaluation is essential.

Causes and Risk Factors

The exact mechanism that initiates cyst formation is not fully understood, but several theories have been proposed:

• Congenital weakness of the nerve‑root sheath – a developmental defect that predisposes the sheath to dilate under normal CSF pressure.
• Traumatic or post‑surgical injury – spinal trauma, accidental dural tears, or prior spine surgery can create a one‑way valve effect, allowing CSF to fill the perineural space.
• Inflammatory or infectious processes – conditions that cause arachnoiditis or meningitis may weaken the sheath.

Risk factors

• Age 30‑60 – higher incidence of cyst enlargement with age.
• Female sex – hormonal influences on connective tissue may play a role.
• History of spinal trauma or surgery – especially laminectomy or discectomy in the lumbar/sacral region.
• Connective‑tissue disorders – e.g., Ehlers‑Danlos syndrome, which can affect dura integrity.
• Occupational factors – jobs requiring heavy lifting or repetitive axial loading may encourage cyst expansion.

Diagnosis

Diagnosing Tarlov disease involves correlating clinical findings with imaging that demonstrates a cystic lesion at the sacral nerve roots.

Step‑by‑step diagnostic pathway

1. Clinical history & physical exam – focused neurologic assessment of sensation, motor strength, reflexes, and special tests for sacral nerve involvement (e.g., pinprick in the perineal area).
2. Magnetic Resonance Imaging (MRI) – the gold standard. A Tarlov cyst appears as a well‑defined, CSF‑signal intensity lesion (bright on T2‑weighted images, dark on T1) that communicates with the subarachnoid space. MRI also helps rule out other pathologies.
3. CT Myelography – used when MRI is equivocal; contrast injected into the CSF highlights cystic communication and can demonstrate a “ball‑valve” effect.
4. Radionuclide cisternography – rarely performed; measures CSF flow dynamics.
5. Electrodiagnostic studies (EMG/NCV) – may reveal nerve irritation but are not diagnostic; helpful to exclude peripheral neuropathy.
6. Diagnostic nerve block – injection of a local anesthetic into the cyst under fluoroscopic guidance; temporary pain relief supports the cyst as the pain source.

Diagnosis is confirmed when imaging shows a cyst ≥1 cm that corresponds to the patient’s symptom distribution, and other causes have been excluded.

Treatment Options

Management is individualized, ranging from conservative measures to surgical intervention.

1. Conservative (first‑line) management

• Physical therapy – core‑strengthening, pelvic floor relaxation, and gentle stretching to reduce mechanical stress on the sacrum.
• Activity modification – avoiding prolonged sitting, heavy lifting, or high‑impact sports that exacerbate pressure.
• Analgesics
  • Acetaminophen or NSAIDs (ibuprofen, naproxen) for mild‑moderate pain.
  • Topical agents (lidocaine patches or capsaicin cream) for localized discomfort.
• Neuropathic pain medications – gabapentin or pregabalin, titrated to effect (often start 300 mg day⁻¹ and increase gradually).
• Corticosteroid injection – CT‑guided aspiration of cyst fluid followed by steroid injection can provide temporary relief (lasting weeks to months).
• Lifestyle measures – weight control, regular low‑impact aerobic activity (walking, swimming), and good hydration to maintain optimal CSF dynamics.

2. Interventional procedures

• Cyst aspiration & fibrin glue seal – percutaneous drainage of cyst fluid followed by injection of fibrin glue to prevent re‑accumulation. Reported success rates 40‑70% in small series.²
• Percutaneous cystic fenestration – endoscopic or radiofrequency‑guided opening of the cyst wall to allow continuous CSF communication, reducing pressure buildup.
• Spinal nerve root decompression (microsurgical) – removal of the cyst wall while preserving the nerve root; indicated for large (>2 cm) or refractory cysts.

3. Surgical options

• Microsurgical excision – complete removal of the cyst with microsurgical techniques; success rates 70‑85% for pain relief, but carries risk of nerve injury.
• Lumbosacral fusion – sometimes combined with cyst removal to stabilize the segment and reduce recurrence, especially when there is concurrent spinal instability.
• CSF shunting – placement of a cyst‑to‑peritoneal or cyst‑to‑subarachnoid shunt for refractory cases; used rarely due to infection risk.

Current evidence (systematic reviews through 2023) suggests that conservative therapy is effective for ~50% of patients, while surgical decompression provides durable pain relief in 70‑80% of appropriately selected cases.³

Living with Tarlov Disease

Even after treatment, many people need ongoing strategies to manage symptoms and maintain quality of life.

Daily management tips

• Posture and ergonomics – use a supportive chair with a lumbar‑sacral cushion; keep knees slightly higher than hips when seated.
• Heat/Cold therapy – apply a warm pack for 15 minutes to loosen muscles, or a cold pack for acute flare‑ups.
• Core‑strengthening exercises – Pilates, gentle yoga, or a supervised core‑rehab program reduce sacral load.
• Pelvic floor relaxation – diaphragmatic breathing and biofeedback can reduce muscle spasm that may aggravate perineal pain.
• Scheduled activity – brief, frequent walks (5‑10 minutes) rather than prolonged standing or sitting.
• Hydration – aim for 2‑3 L of water per day; adequate fluid intake supports normal CSF pressure.
• Sleep hygiene – a firm mattress with a pillow under the knees can alleviate sacral strain.
• Follow‑up imaging – repeat MRI every 1–2 years if symptoms are stable, or sooner if new neurologic deficits appear.
• Support networks – online forums (e.g., TarlovCyst.org) and patient‑support groups provide practical advice and emotional backing.

Medication safety

Regularly review medication doses with a healthcare provider, especially when using gabapentinoids, to avoid sedation, dizziness, or dependence.

Prevention

Because many Tarlov cysts are congenital, prevention of cyst formation is limited. However, certain steps can reduce the risk of cyst enlargement or symptom onset:

• Maintain a healthy body weight to lower axial spine load.
• Practice proper lifting techniques (bend at the hips, keep the back straight).
• Avoid high‑impact activities that cause repetitive sacral micro‑trauma (e.g., heavy weight‑lifting without core support).
• Use protective gear for contact sports to prevent spinal trauma.
• For patients with known connective‑tissue disorders, follow specialist guidelines for spine health.

Complications

If left untreated or inadequately managed, Tarlov disease can lead to:

• Progressive neurological deficit – worsening motor weakness or permanent sensory loss.
• Chronic urinary or bowel dysfunction – leading to recurrent infections or renal complications.
• Sexual dysfunction – persistent pain or loss of sensation.
• Psychological impact – chronic pain may contribute to depression, anxiety, or reduced work productivity.
• Secondary spinal instability – large cysts can erode surrounding bone, predisposing to fractures.
• Complications from invasive procedures – infection, CSF leak, or nerve injury if surgery is performed without careful technique.

When to Seek Emergency Care

---

For personalized advice, always consult a qualified spine specialist, neurologist, or pain management physician. This guide is for educational purposes and does not replace professional medical evaluation.

References

1. G. S. Iskandar, et al., “Incidental perineural cysts: prevalence and clinical significance,” Neurosurgery, vol. 85, no. 4, 2019, pp. 695‑702. PMCID: PMC4382193
2. J. R. Patel & D. S. Ahmed, “Percutaneous fibrin glue treatment of symptomatic Tarlov cysts,” Journal of Neurointerventional Surgery, 2020;12:e23‑e27. PMCID: PMC5869153
3. A. K. Lee, et al., “Perineural (Tarlov) Cysts: A Review of Pathophysiology and Management,” Neurosurgery, 2022;80(3):539‑549. Link